The increased frequency and number of innate and adaptive immune cells in IL-33 - expressing tumours supports the conclusion that tumour-infiltrating immune cells mediate protective anti-tumour immunity in murine lung carcinoma. This evidence concerns the gene IL33 and lung carcinoma.